| 000 | 01691 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515143758.0 | ||
| 264 | 0 | _c20090106 | |
| 008 | 200901s 0 0 eng d | ||
| 022 | _a1879-1913 | ||
| 024 | 7 |
_a10.1016/j.amjcard.2008.06.060 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aParaskevaidis, Ioannis A | |
| 245 | 0 | 0 |
_aUsefulness of dobutamine-induced changes of the two-dimensional longitudinal deformation predict clinical and neurohumoral improvement in men after levosimendan treatment in acutely decompensated chronic heart failure. _h[electronic resource] |
| 260 |
_bThe American journal of cardiology _cNov 2008 |
||
| 300 |
_a1225-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
| 650 | 0 | 4 |
_aDobutamine _xpharmacology |
| 650 | 0 | 4 | _aEchocardiography, Stress |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Failure _xblood |
| 650 | 0 | 4 |
_aHeart Ventricles _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrazones _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNatriuretic Peptide, Brain _xblood |
| 650 | 0 | 4 |
_aPyridazines _xtherapeutic use |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSimendan |
| 650 | 0 | 4 | _aStroke Volume |
| 700 | 1 | _aBistola, Vassiliki | |
| 700 | 1 | _aIkonomidis, Ignatios | |
| 700 | 1 | _aParissis, John T | |
| 700 | 1 | _aPapadopoulos, Constantinos | |
| 700 | 1 | _aFilippatos, Gerasimos | |
| 700 | 1 | _aKremastinos, Dimitrios T | |
| 773 | 0 |
_tThe American journal of cardiology _gvol. 102 _gno. 9 _gp. 1225-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.amjcard.2008.06.060 _zAvailable from publisher's website |
| 999 |
_c18403427 _d18403427 |
||